Location & Type arrow_drop_up Concepts arrow_drop_down Orgs arrow_drop_down
Filter by Concept
#1
Nicolas Mounier
Nicolas Mounier
Onco-Haematology Department, Hospital l'Archet, 151 Route de Saint Antoine-Ginestière, 06000 Nice, France. mounier.n@chu-nice.fr
Known for star star star star star
Follicular Lymphoma | High-Dose Therapy | International Prognostic | Response Rate
#2
James Olen Armitage
James Olen Armitage
San Raffaele Scientific Institute, Milan, Italy Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Eppley Cancer Center, University of Nebraska Medical ...
Known for star star star star star
Bone Marrow | High-Dose Therapy | Follicular Lymphoma | Chromosomal Abnormalities

#3
Eva K. Kimby
Eva K. Kimby
Department of Medicine, Section of Hematology, Danderyd Hospital, Danderyd, and the Department of Clinical Immunology, Huddinge Hospital, Huddinge, Sweden
Known for star star star star star
Follicular Lymphoma | Chronic Lymphocytic Leukemia | Advisory Committees | Rituximab Maintenance
#4
Krimo Bouabdallah
Krimo Bouabdallah
CHU Bordeaux, Service d’Hématologie et Thérapie Cellulaire, Bordeaux, France
Known for star star star star star_half
Advisory Committees | Entitys Board | Speakers Bureau | Intensive Chemotherapy
#5
Harald JR. Holte
Harald JR. Holte
From the Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.J.S.); the Hematopoietic Cellular Therapy Program, University of Chicago ...
Known for star star star star star_half
Advisory Committees | Entitys Board | Follicular Lymphoma | High-Dose Therapy
#6
James L. Gajewski
James L. Gajewski
From the Departments of Leukemia, Bioimmunotherapy,Biostatistics, and Blood and Bone Marrow Transplantation,M.D. Anderson Cancer Center, Houston, TX; and the National ...
Known for star star star star star_border
Marrow Transplant | High-Dose Chemotherapy | Unrelated Donors | Acute Myelogenous Leukemia
#7
Giuseppe Dastoli
Giuseppe Dastoli
From the Department of Oncology, University of Milan, Milan, Italy; the Divisions of Medical Oncology C, Radiotherapy, and Pathology, National Cancer Institute, Milan, Italy; ...
Known for star star star star star_border
Vivo Purging | Rituximab Infusion | Indolent Lymphoma | Cd34-Containing Peripheral Blood Harvests
#8
Sadao Aoki
Sadao Aoki
From the First Department of Internal Medicine, Toho University School of Medicine, Tokyo; Research Institute, Saitama Cancer Center, Saitama; the Department of Internal ...
Known for star star star star star_border
Tafro Syndrome | Malignant Lymphoma | Prognostic Factor | Hematological Malignancies
#9
Monica Astolfi
Monica Astolfi
Department of Medicine and Experimental Oncology, Division of Haematology, University of Torino, Azienda Ospedaliera San Giovanni Battista, Torino, Italy,
Known for star star star star star_border
Minimal Residual | Molecular Remission | Tumor Cells | Breast Cancer
#10
Forrest Swan
Forrest Swan
University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Known for star star star star star_border
Flow Cytometry | Low-Grade Lymphoma | Combination Chemotherapy | Response Rate
#11
Andreas Draube
Andreas Draube
University of Cologne, Department of Internal Medicine I, Cologne, Germany
Known for star star star star star_border
Bone Marrow | Nude Mice | Platelet Contamination | High-Dose Chemotherapy
#12
A. V. M. B. Schattenberg
A. V. M. B. Schattenberg
Dept. of Hematology, University Hospital Nijmegen, P. O. Box 9101, NL-6500 HB, Nijmegen, The Netherlands
Known for star star star star star_border
Drug Solutions | Bone Marrow | Interferon Alfa | Substantial Loss
#13
Ying Yang
Ying Yang
Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Known for star star star star star_border
Breast Carcinoma | Neoadjuvant Chemotherapy | Tumor Cellularity | Erbb2 Overexpression
#14
Federico Papineschi
Federico Papineschi
Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Ospedale S. Chiara, Via Roma, 56, 56100 PISA, Italy
Known for star star star star star_border
Infectious Complications | Polycythemia Vera | Oral Mucositis | Chronic Myeloid Leukemia
#15
Giulia Cervetti
Giulia Cervetti
Hematology Division, Department of Oncology, Transplants and Advanced Technologies, University of Pisa, Pisa, Italy. m.petrini@med.unipi.it
Known for star star star star star_border
Chronic Myeloid Leukemia | Splenic Marginal Zone Lymphoma | Dexrazoxane Supplementation | Minimal Residual
#16
Takumi Oshima
Takumi Oshima
Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510 Japan
Known for star star star star star_border
Takayasu Arteritis | Tumor Identification | Vessel Uptake | Aggressive Indolent Lymphomas
#17
Ming Tian
Ming Tian
Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China
Known for star star star star star_border
Cdk1 Sirna | Breast Cancer | Sf3b1 Mutation | Lupus Nephritis

 

Recently Asked Questions

View all FAQs

Lymphangioma Lymphangiomas are benign tumors that usually appear at birth or in early childhood. These tumors arise from the lymphatic system, which is a network of...

 

Myeloproliferative Disorder Myeloproliferative disorder is a type of blood cancer that affects the production of white blood cells in the bone marrow. The term myeloproliferative...

 

Small Lymphocytic Lymphoma small lymphocytic lymphoma (SLL) is a type of non-Hodgkin's lymphoma that develops from mature B-cells. It most commonly affects people over the age of 60,...

 

A precancerous skin lesion is a growth or mark on the skin that could become cancerous if not treated. These lesions are usually found on areas of the skin...

 

Ependymoma Ependymoma is a type of brain tumor that arises from the ependymal cells lining the ventricles or central canal of the spinal cord. These cells are...

 

Oral Hepatitis C Treatment For Indolent Lymphoma (Optimal) Study. Oral Hepatitis...

[ CLINICAL_TRIAL ] ... grade lymphoma. Thus, the hypothesis of this study is that oral HCV therapy will lead to a high rate of hepatitis C eradication which will correlate with a reduction of the size and extent ...
Known for star star star star star
Oral Hepatitis | Cirrhosis Sofosbuvir | Grade Lymphoma | Ribavirin Hodgkin

Multicenter Phase Ii Study For Zevalin® In Patients With Relapsed/refractory...

[ CLINICAL_TRIAL ] ... to lymphoma cells, causing them to die.Before you can start treatment on this study, you will have what are called "screening tests." These tests will help the doctor decide if you are ...
Known for star star star star star
Marginal Lymphoma | Ibritumomab Tiuxetan | Bone Marrow | Rituximab Vein

A Phase 1 Study Of Venetoclax With Obinutuzumab And Magrolimab (Venom) In...

[ CLINICAL_TRIAL ] ... an indolent B-cell lymphoma whose disease has returned or progressed after other treatment. Indolent B-cell lymph
Known for star star star star star_half
Refractory Indolent | Magrolimab Obinutuzumab | Cycles Venetoclax | Triplet Combination

Phase Ii Study Of Irinotecan For The Treatment Of Relapsed Or Refractory...

[ CLINICAL_TRIAL ] ... vs indolent vs mantle cell lymphoma). Patients with aggressive and indolent lymphoma are further stratified as to being refractory (no complete response (CR) or partial response (PR) to initial ther
Known for star star star star star_half
Lymphoma Irinotecan | Recurrent Refractory | Indolent Nhlstratum | Aggressive Hodgkin

Phase Ii Study Of Rituximab In Combination With Fludarabine And Cyclophosphamide...

[ CLINICAL_TRIAL ] ... anti-lymphoma activity of the FC+R combination. Detailed Description The natural history of follicular lymphomas is characterized by a high initial response rate to chemotherapy followed ...
Known for star star star star star_border
Follicular Lymphoma | Fcr Combination | Safety Profile | Fludarabine Cyclophosphamide

Phase Ii Study Of Rituximab And Acalabrutinib In Newly Diagnosed B Cell Post...

[ CLINICAL_TRIAL ] The purpose of this study is to evaluate how effective rituximab and acalabrutinib are when given as a combination treatment for newly diagnosed B cell post transplant lymphoproliferative ...
Known for star star star star star_border
Newly Diagnosed | Post Transplant | Lymphoproliferative Disorder | Acalabrutinib Rituximab

Non‐hodgkin Lymphoma In Elderly Patients

[ PUBLICATION ] ... for indolent lymphoma group and aggressive lymphoma group separately. RESULTS: The median patient age was 75 years (range, 70-90 years), and 83% of the patients examined were male. ...
Known for star star star star star_border
Aggressive Lymphoma | Performance Status | Anthracycline-Containing Regimen | Age Groups

Whole-Body Mri For The Detection Of Bone Marrow Involvement In Lymphoma:...

[ PUBLICATION ] ... and indolent lymphomas separately.ResultsSensitivity of whole-body MRI in all lymphomas was 45.5 % [95 % confidence interval (CI): 29.8–62.0 %]. Sensitivity of whole-body MRI in aggressive lymphoma
Known for star star star star star_border
Whole-Body Mri | Bone Marrow | Indolent Lymphoma | Fdg Pet

Successful In Vivo Purging Of Cd34-Containing Peripheral Blood Harvests In Mantle...

[ PUBLICATION ] ... follicular lymphoma and bone marrow involvement. In a prospective study, 15 patients with CD20+ mantle cell or follicular lymphoma, bone marrow involvement, and polymerase chain reaction ...
Known for star star star star star_border
Vivo Purging | Rituximab Infusion | Indolent Lymphoma | Cd34-Containing Peripheral Blood Harvests

Successful In Vivo Purging Of Cd34-Containing Peripheral Blood Harvests In Mantle...

[ PUBLICATION ] ... follicular lymphoma and bone marrow involvement. In a prospective study, 15 patients with CD20(+) mantle cell or follicular lymphoma, bone marrow involvement, and polymerase chain reaction ...
Known for star star star star star_border
Vivo Purging | Rituximab Infusion | Indolent Lymphoma | Cd34-Containing Peripheral Blood Harvests